After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...

Arcellx (ACLX) and Legend Biotech (LEGN) traded higher on Tuesday after the U.S. FDA issued draft guidance on the use of minimal residual disease and complete response as study endpoints that can ...

Daratumumab and hyaluronidase-fihj is now FDA-approved for newly diagnosed multiple myeloma patients ineligible for ASCT, in combination with VRd. The phase 3 CEPHEUS trial showed significant ...

Pharmacokinetics and Safety of Selumetinib Granule Formulation in Children With Symptomatic, Inoperable Neurofibromatosis Type 1-Related Plexiform Neurofibromas (SPRINKLE; phase I/II) For over half a ...

DEAR DR. ROACH: I am an 82-year old man who was in good health until I found out that I have an issue in my left kidney. My ...

Multiple myeloma (MM) is a genetically complex and heterogenous malignancy with a 5-year survival rate of approximately 60%. Patients experience periods of relapse and remission, with prognosis ...

Everton’s Jack Grealish has sustained a suspected stress fracture in his foot that could keep him out for a number of months. The attacker will be seen by a specialist in the coming days, after which ...

The first road stage of the men's Tour Down Under on Wednesday also saw the first crashes and abandons, with Marius Mayrhofer (Tudor Pro Cycling) and Max van der Meulen (Bahrain Victorious) both ...

The stock currently trades at $67.72, down nearly 39% over the past year and hovering just above its 52-week low of $65.39. The price target reduction primarily reflects recent comparable multiple ...

The price target reduction primarily reflects "recent comparable multiple compression and ongoing macro spending concerns impacting enterprise software," according to Rosenblatt’s research note. In ...

Word of the day: Multiple compression is one of those quiet market forces that can reshape investor returns without warning. It often shows up during periods when stock prices fall even as company ...